Xue‐Ping Li

机构：Hebei Medical University, Sun Yat-sen University, Fourth Hospital of Hebei Medical University, Xi'an Medical University, Sun Yat-sen University Cancer Center, Chengdu University of Traditional Chinese Medicine · ORCID：0000-0002-4588-065X

发表论文 67 篇 · 总被引 1034 次 · h-index 19

代表论文

• Exploring the role of curcumin in mitigating oxidative stress to alleviate lipid metabolism disorders (2025 · Frontiers in Pharmacology · 被引 38)
• Sintilimab (anti-PD-1 antibody) plus chidamide (histone deacetylase inhibitor) in relapsed or refractory extranodal natural killer T-cell lymphoma (SCENT): a phase Ib/II study (2024 · Signal Transduction and Targeted Therapy · 被引 36)
• Natural flavonoids derived from herbal medicines are potential anti-atherogenic agents by inhibiting oxidative stress in endothelial cells (2023 · Frontiers in Pharmacology · 被引 16)
• Multi-omics analyses of tumor-associated immune-infiltrating cells with the novel immune checkpoint protein tyrosine phosphatase 1B (PTP1B) in extracellular matrix of brain-lower-grade-glioma (LGG) and uveal-melanoma (UVM) (2022 · Frontiers in Immunology · 被引 10)
• Recent advances in AIE-based platforms for cancer immunotherapy (2024 · Journal of Controlled Release · 被引 8)
• A multi-omic single-cell landscape reveals transcription and epigenetic regulatory features of t(8;21) AML (2025 · Journal of Translational Medicine · 被引 6)